DNA bending is induced by binding of the glucocorticoid receptor DNA binding domain and progesterone receptors to their response element

Journal of Steroid Biochemistry and Molecular Biology

Volumn 60, Issue 1-2, 1997, Pages 31-41

  Petz, Larry N ^a   Nardulli, Ann M ^b   Kim, Jongsook ^a   Horwitz, Kathryn B ^c   Freedman, Leonard P ^d   Shapiro, David J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DNA BINDING; DNA STRUCTURE; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DNA BINDING; PROTEIN DOMAIN;

BINDING SITES; DIMERIZATION; DNA; HUMANS; NUCLEIC ACID CONFORMATION; PLASMIDS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; REGULATORY SEQUENCES, NUCLEIC ACID;

EID: 0030995770     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00171-9     Document Type: Article

References (54)

1. Tsai M.-J. and O'Malley B. W.: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63 (1994) 451-486.
2. Ptashne M.: Gene regulation by proteins acting nearby and at a distance. Nature 322 (1989) 697-701.
3. Horowitz D. and Wang J. C.: Torsional rigidity of DNA and lenght dependence of the free energy of DNA supercoiling. J. Molec. Biol. 173 (1984) 75-91.
4. Kim J., Zwieb C., Wu C. and Adhya S.: Bending of DNA by gene-regulatory proteins: construction and use of a DNA bending vector. Gene 85 (1989) 15-23.
5. Wu H.-M. and Crothers D. M.: The locus of sequence-directed and protein-induced DNA bending. Nature 308 (1984) 509-513.
6. van der Vliet P. C. and Verrijzer C. P.: Bending of DNA by transcription factors. BioEssays 15 (1993) 25-32.
7. Nardulli A. M. and Shapiro D. J.: Binding of the estrogen receptor DNA-binding domain to the estrogen response element induces DNA bending. Molec. Cell. Biol. 12 (1992) 2037-2042.
8. Nardulli A. M., Greene G. L. and Shapiro D. J.: Human estrogen receptor bound to an estrogen response element bends DNA. Molec. Endocr. 7 (1993) 331-340.
9. Sabbah M., Le Ricousse S., Redeuilh G. and Baulieu E.-E.: Estrogen receptor-induced bending of the Xenopus vitellogenin A2 gene hormone response element. Biochem. Biophys. Res. Commun. 185 (1992) 944-952.
10. King I. N., Soyza T. d., Catanzaro D. F. and Lavin T. N.: Thyroid hormone receptor-induced bending of specific DNA sequences is modified by an accessory factor. J. Biol. Chem. 286 (1993) 495-501.
11. Shulemovich K., Dimaculangan D. D., Katz D. and Lazar M. A.: DNA bending by thyroid hormone receptor: influence of half-site spacing and RXR. Nucl. Acids Res. 23 (1995) 811-818.
12. Lu X. P., Eberhardt N. L. and Pfahl M.: DNA bending by retinoid X receptor-containing retinoid and thyroid hormone receptor complexes. Molec. Cell. Biol. 13 (1993) 6509-6519.
13. Leidig F., Shepard A. R., Zhang W., Stelter A., Cattini P. A., Baxter J. D. and Eberhardt N. L.: Thyroid hormone responsiveness in human growth hormone-related genes: possible correlation with receptor-induced DNA conformational changes. J. Biol. Chem. 267 (1992) 913-921.
14. Wickelgren I.: Protein sculptors that help turn on genes. Science 270 (1995) 1587-1588.
15. Pérez-Martin J. and Espinosa M.: Protein-induced bending as a transcriptional switch. Science 260 (1993) 805-807.
16. Kim J., Klooster S. and Shapiro D. J.: Intrinsically bent DNA in a eukaryotic transcription factor recognition sequence potentiates transcription activation. J. Biol. Chem. 270 (1995) 1282-1288.
17. Oakley R. H., Sar M. and Cidlowski J. A.: The human glucocorticoid receptor B isoform. J. Biol. Chem. 271 (1996) 9550-9559.
18. Schrader W. T. and O'Malley B. W.: Progesterone-binding components of chick oviduct: characterization of purified subunits. J. Biol. Chem. 247 (1972) 51-59.
19. Horwitz K. B. and Alexander P. S.: In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 113 (1983) 2195-2201.
20. Vegeto E., Shahbaz M. M., Wen D. X., Goldman M. E., O'Malley B. W. and McDonnell D. P.: Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Molec. Endocr. 7 (1993) 1244-1255.
21. Tung L., Mohamed M. K., Hoeffler J. P., Takimoto G. S. and Horwitz K. B.: Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Molec. Endocr. 7 (1993) 1256-1265.
22. Mohamed M. K., Tung L., Takimoto G. S. and Horwitz K. B.: The leucine zippers of c-fos and c-jun for progesterone receptor dimerization: A-dominance in the A/B heterodimer. J. Steroid Biochem. Molec. Biol. 51 (1994) 241-250.
23. Conneely O. M., Kettelberger D. M., Tsai J. J., Schrader W. T. and O'Malley B. W.: The chicken progesterone receptor A and B isoforms are products of an alternate translation initiation event. J. Biol. Chem. 264 (1989) 14062-14064.
24. Kastner P., Kurst A., Turcotte B., Stropp U., Tora L., Gronemeyer H. and Chambon P.: Two distinct estrogen-regulated promoters generate transcripts encoding two functionally different human progesterone receptor forms A and B. EMBO J. 9 (1990) 1603-1614.
25. Sartorius C. A., Melville M. Y., Hovland A. R., Tung L., Takimoto G. S. and Horwitz K. B.: A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B isoform. Molec. Endocr. 8 (1994) 1347-1360.
26. Lieberman B. A., Bona B. J., Edwards D. P. and Nordeen S. K.: The constitution of a progesterone response element. Molec. Endocr. 7 (1993) 515-527.
27. Luisi V. F., Xu W. X., Otwinowski Z., Freedman L. P., Yamamoto K. R. and Sigler P. B.: Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352 (1991) 497-505.
28. Sartorius C. A., Groshong S. D., Miller L. A., Powell R. L., Tung L., Takimoto G. S. and Horwitz K. B.: New T47D breast cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonist by cAMP. Cancer Res. 54 (1994) 3868-3877.
29. Keydar I., Chen L., Karbey S., Weiss F. R., Delarea J., Radu M., Chaitcik S. and Brenner H. J.: Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer 15 (1979) 659-670.
30. Alroy I. and Freedman L. P.: DNA binding analysis of glucocorticoid receptor specificity mutants. Nucl. Acids Res. 20 (1992) 1045-1052.
31. Nardulli A. M., Lew D., Erijman L. and Shapiro D. J.: Purified estrogen receptor DNA binding domain expressed in Escherichia coli activates transcription of an estrogen-responsive promoter in cultured cells. J. Biol. Chem. 266 (1991) 24070-24076.
32. Chodosh L. A.: Mobility shift DNA-binding assay using gel electrophoresis. In Current Protocols in Molecular Biology (Edited by Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A. and Struhl K.). Greene Publishing Associates and Wiley Interscience, New York (1989) pp. 12.2.1-12.2.10.
33. Thompson J. F. and Landy A.: Empirical estimation of protein-induced DNA bending angles: applications to λ site-specific recombination complexes. Nucl. Acids Res. 16 (1988) 9687-9705.
34. Xu W., Alroy I., Freedman L. P. and Sigler P. B.: Stereochemistry of specific steroid receptor-DNA interactions. Cold Spring Harbor Symposia on Quantitative Biology, Vol. 58 (1993) pp. 133-139.
35. Oñate S. A., Prendergast P., Wagner J. P., Nissen M., Reeves R., Pettijohn D. E. and Edwards D. P.: The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Molec. Cell. Biol. 14 (1994) 3376-3391.
36. Koo H.-S., Drak J., Rice J. A. and Crothers D. M.: Determination of the extent of DNA binding by an adenine-thymine tract. Biochem. J. 29 (1990) 4227-4234.
37. Nardulli A. M., Grobner C. and Cotter D.: Estrogen receptor-induced DNA bending: orientation of the bend and replacement of an estrogen response element with an intrinsic DNA bending sequence. Molec. Endocr. 9 (1995) 1064-1076.
38. Nardulli A. M., Romine L. E., Carpo C., Greene G. L. and Rainish B.: Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Molec. Endocr. 10 (1996) 694-704.
39. Gartenberg M. R. and Crothers D. M.: DNA sequence determinants of CAP-induced bending and protein binding affinity. Nature 333 (1988) 824-831.
40. Bishop T. C. and Schulten K.: Molecular dynamics study of glucocorticoid receptor-DNA binding. PROTEINS: Struct. Funct. Genet. 24 (1996) 115-133.
41. Potthoff S. J., Romine L. R. and Nardulli A. M.: Effects of wild type and mutant estrogen receptors on DNA flexibility, DNA bending, and transcription activation. Molec. Endocr. 10 (1966) 1095-1106.
42. Prendergast P., Pan Z. and Edwards D. P.: Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms. Molec. Endocr. 10 (1996) 393-407.
43. Yang C. C. and Nash H. A.: The interaction of E. coli IHF protein with its specific binding sites. Cell 57 (1989) 869-880.
44. Schultz S. C., Shields G. C. and Steitz T. A.: Crystal structure of a CAP-DNA complex: the DNA is bent by 90°. Science 253 (1991) 1001-1007.
45. Ferrari S., Harley V. R., Pontiggia A., Goodfellow P. N., Lovell-Badge R. and Bianchi M. E.: SRY, like HMG1, recognizes sharp angles in DNA. EMBO J. 11 (1992) 4497-4506.
46. Kerppola T. K. and Curran T.: Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity. Cell 66 (1991) 317-326.
47. Foster J. W., Domingue-Steglich M. A., Guioli S., Kwok C., Weller P. A., Stevanovic M., Weissenbach J., Mansour S., Young I. D., Goodfellow P. N., Brook J. D. and Schafer A. J.: Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372 (1994) 525-530.
48. Giese K., Cox J. and Grosschedl R.: The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69 (1992) 185-195.
49. Love J. J., Li X., Case D. A., Giese K., Grosschedl R. and Wright P. E.: Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376 (1995) 791-795.
50. Parvin J. D., McCormick R. J., Sharp P. A. and Fisher D. E.: Pre-bending of a promoter sequence enhances affinity for the TATA-binding factor. Nature 373 (1995) 724-727.
51. Ten A. H. and Biggin M. D.: Bending DNA can repress a eukaryotic basal promoter and inhibit TFIID binding. Molec. Cell. Biol. 15 (1995) 5492-5498.
52. Huber H. E., Goodhart P. J. and Huang P. S.: Retinoblastoma protein reverses DNA bending by transcription factor E2F. J. Biol. Chem. 269 (1994) 6999-7005.
53. Schodin D. J., Zhuang Y., Shapiro D. J. and Katzenellenbogen B. S.: Analysis of mechanisms that determine dominant negative estrogen receptor effectiveness. J. Biol. Chem. 270 (1995) 31163-31171.
54. Kumar V. and Chambon P.: The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55 (1988) 145-156.